Well done Lostout for finding this info.
I recall that there were multiple dose segments of the previous Phase2 and that the highest doseage was the same as in the upcoming Phase3, and ran for the same time scale as mentioned in this update
I wonder if the (sucessful) results from the Phase2 can be added into the upcoming Phase3 as additional data points? Maybe even the placebo also?
I wonder why so many placebo patients? ... 90 seems very high .. I was expecting perhaps 120 active and 60 placebo.
Any thoughts?
.
Trial details, page-7
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |